CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Firefly Neuroscience Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Firefly Neuroscience Inc
1100 Military Road
KENMORE, NY  14217  United States Ticker: AIFFAIFF
Business Summary
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes---

Industries
SIC Code Description
7372 Prepackaged software
7371 Computer programming services
7373 Computer integrated systems design

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Arun S.Menawat 70 3/10/2025 8/12/2024
Chief Executive Officer, Director GregLipschitz 3/26/2025 8/12/2024
Director DavidDecaprio 8/12/2024 8/12/2024
Director Brian M.Posner 62 8/12/2024 8/12/2024
Director StellaVnook 8/19/2024 8/19/2024

Subsidiaries
Business Name Address City State/Province Country
Evoke Neuroscience, Inc 1115 Broadway, 12th Floor New York NY United States

Business Names
Business Name
AIFF
Evoke Neuroscience, Inc
FFN Merger Sub
6 additional Business Names available in full report.

General Information
Number of Employees: 13 (As of 3/31/2025)
Outstanding Shares: 11,622,952 (As of 3/25/2025)
Shareholders: 380
Stock Exchange: NASD
Federal Tax Id: 541167364
Fax Number: (302) 655-5049
Email Address: info@fireflyneuro.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, May 13, 2025